Sutro Biopharma Inc
STRO
Market Cap$73.52M
Close$
$-0.02
102.7% downside
Current Fair Value
102.7% downsideOvervalued by 102.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $73.52 Million |
|---|---|
| Enterprise Value | $-23,826,384.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.96 |
| Beta | 1.78 |
| Outstanding Shares | 82,526,430 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.32 |
|---|---|
| PEG | 31.35 |
| Price to Sales | 0.87 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.15 |
| Enterprise Value to EBIT | 0.18 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -3.9 |
| Debt to Equity | 2.08 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sutro Biopharma Inc
CEO: William Newell